1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63BCF34B2DD1DCBE585257F41006EEC90
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/3BCF34B2DD1DCBE585257F41006EEC90!OpenDocument
18
19OpenDocument
2018.97.14.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Digital Technology » Investment Benchmarks

Document Excerpt: Finding & Showcasing Digital Impact: Measuring Return on Investment

DB Image

ID: MD-500


Features:

7 Info Graphics

17 Data Graphics

400 Metrics


Pages/Slides: 4


Published: Pre-2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5399 "Finding & Showcasing Digital Impact: Measuring Return on Investment".

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Manufacturing; Consumer Products; Diagnostic; Health Care; Marketing; Biopharmaceutical; Clinical Research; Laboratories; Chemical


Companies Profiled:
Novartis; Bristol-Myers Squibb; Roche; Astellas; Bayer; Teva Pharmaceutical Industries Ltd; Mylan; Ipsen; Alcon; Abbott; Eisai; Triplefin; Sanofi; cipla; Merck; Ferring Pharmaceuticals; Boehringer Ingelheim; Biogen; UCB Pharma; Hospira; Johnson & Johnson; GlaxoSmithKline ; Baxter Healthcare; Olympus Corporation; Sun Pharmaceutical; AstraZeneca; Abbvie; Genentech; Clarus Therapeutics; Zydus

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.